In addition, at present there are three ongoing clinical studies with Xeomin: • In the upper limb spasticity study (MRZ 0410) 144 patients entered the second injection cycle, in which doses up to 400 U of Xeomin are administered. • In the cervical dystonia study (MRZ 0408) in which doses up to 240 U of Xeomin are administered, 31 patients entered the second injection cycle. • In the blepharospasmus study (MRZ 0433) one patient has entered the second injection cycle.